Updates to our Terms of Use

We are updating our Terms of Use. Please carefully review the updated Terms before proceeding to our website.

Sunday, May 19, 2024 | Back issues
Courthouse News Service Courthouse News Service

Shareholder Class Action

PHOENIX - Insys Therapeutics goosed its share price with false and deceptive statements and unethical ads about its Subsys drug, and the price dropped by 17% in a day when the truth came out, shareholders claim in a federal class action.

Categories / Uncategorized

Subscribe to Closing Arguments

Sign up for new weekly newsletter Closing Arguments to get the latest about ongoing trials, major litigation and hot cases and rulings in courthouses around the U.S. and the world.

Loading...